is glp 1 an incretin GLP-1 released from the small intestine after meal ingestion and Incretin hormones and the satiation

On average, patients can expect to lose 15-20% of their body weight when using oral GLP-1 weight loss medications

That number surpasses anything recorded with semaglutide (approximately 15-16%) or tirzepatide (approximately 20-22%)

Some reports observed that ACEi fail to inhibit ACE2 (Turner et al., 2002) and suggested that small peptide specific ACE2 inhibitors as DX600 as more efficient inhibiting SARS-CoV cell entry in vitro (Sukumaran et al., 2011), as well as urinary excretion in olmesartan-treated hypertensive patients (Kuba et al., 2005)

I.ClaesK.BammensB.De LoorH.ViaeneL.VerbekeK.et al (2010)

However, we argue that lacking adjustment of these factors will not bias our results because these factors might act as mediators instead of confounding factors based on the available evidence that poor glucose control will lead to DR, whereas using GLP-1 RAs will help to control glucose control